CGON vs ULTA · rev $4.0M vs P/E 17, rev $3.04B
CG Oncology, Inc. Common stock (CGON) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
CGON currently screens at market cap $4.74B. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the CGON and ULTA stock pages for the full models.
Not investment advice.